Glasgow, United Kingdom

Norman Shankland

This inventor holds 2 USPTO granted patents. Top assignee: Columbia University. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norman Shankland. Retrieved from https://idiyas.com/inventor/norman-shankland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Norman Shankland

Introduction

Norman Shankland is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of organic materials, particularly in the characterization of small molecule organic materials. With a total of 2 patents to his name, Shankland's work has implications for drug development and analysis.

Latest Patents

Shankland's latest patents focus on the X-ray characterization of solid small molecule organic materials. The present invention provides methods for characterizing small molecule organic materials, such as drugs or drug products. This method includes subjecting the solid small molecule organic material to X-ray total scattering analysis at a short wavelength, collecting data generated thereby, and mathematically transforming the data to provide a refined set of data.

Career Highlights

Norman Shankland is affiliated with Columbia University, where he continues to advance research in his field. His work has been instrumental in enhancing the understanding of organic materials and their properties.

Collaborations

Shankland has collaborated with notable colleagues, including Simon Billinge and Kenneth Shankland. These collaborations have further enriched his research and contributions to the scientific community.

Conclusion

Norman Shankland's innovative work in the characterization of organic materials has positioned him as a key figure in his field. His patents reflect a commitment to advancing drug analysis and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…